BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Kidney
,
Anticancer prodrugs
,
Clofibrate
,
rs2230926
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
idh1 protein human
Summary
General Info
Curated Studies
Most Correlated Studies
Isocitrate Dehydrogenase (IDH) Mutations in HCT116 isogenic clones
Astroglial SVG cells with IDH1 R132H heterozygous mutation
Hepatoblasts overexpressing wildtype or mutant IDH1 or IDH2
Sarcoma HT-1080 cells treated with the selective R132C mutant IDH1 inhibitor licochalcone A
Acute myeloid leukemia - PBMC gene expression profiles of BCOR mutant and wildtype samples
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahe…
A Comparative Study Between Tumor Blood Vessels and Dynamic Contrast-enhanced MRI for Identifying Is…
A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and g…
Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism i…
Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute …
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or…
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematol…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ